← Leaderboards
David H Manz
University Of Connecticut Sch Of Med/Dnt
$207,266
Attributed
$207,266
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.3K · FY2016–21$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$207,266 · 1
By mechanism
F30$207,266 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Hung Ton-That$17,360,356
- Choukri Ben Mamoun$12,993,342
- Frank M Torti$18,498,870
- Leslie Ann Caromile$1,064,749
- Ernesto Canalis$18,979,065
Others in their field
Top investigators on “Generations”
- Richard A Gibbs · Baylor College Of Medicine$539,942,150
- David Heimbrook · Leidos Biomedical Research, Inc.$461,253,475
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$280,469,869
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
GenerationsBoneExhibitsCancer CellCancer PatientCancer TypeEquilibriumCell GrowthCell MotilityCell PhysiologyCellsCell SurvivalClinically RelevantDiagnosisCell Cycle RegulationBiochemicalDisease ProgressionDistantDna BiosynthesisDna DamageDrug Metabolic DetoxicationEffective TherapyEpithelialGenes
Grant awards (5)
Role of Ferroportin in reducing Prostate Cancer Metastasis$27,390
F30 · FY2021 · DE · contact PI
Role of Ferroportin in reducing Prostate Cancer Metastasis$51,320
F30 · FY2020 · DE · contact PI
Role of Ferroportin in reducing Prostate Cancer Metastasis$50,816
F30 · FY2019 · DE · contact PI
Role of Ferroportin in reducing Prostate Cancer Metastasis$39,636
F30 · FY2018 · DE · contact PI
Role of Ferroportin in reducing Prostate Cancer Metastasis$38,104
F30 · FY2016 · DE · contact PI